 |
| |
| 2020 |
 |
| Educational Webinar |
Presented by:
Vlad Ratziu, MD |
|
|
| |
|
| Best Practices in NASH Management and Current Status of Drug Development |
 |
|
|
|
| |
 |
| Educational Webinar |
Presented by:
Mazen Noureddin, MD |
|
|
| |
|
| Imaging as an Outcome and Endpoint for Clinical Trials of NASH |
|
|
|
|
| |
 |
| Recorded Webinar |
Presented by:
Zobair Younossi, MD
|
|
| |
|
| Release date: |
| Mar 10, 2020 |
| |
| Expiration date: |
| Mar 10, 2021 |
|
 |
| NASH: Current Approach and When Will New Treatment Options Be Available? |
|
|
|
|
|
| |
| 2019 |
| |
 |
| CME Webcast |
Presented by:
Christina Hanson, FNP-C
|
|
| |
|
| Release date: |
| Nov 30, 2019 |
| |
| Expiration date: |
| Nov 30, 2020 |
|
 |
| Emerging therapies and interventions for non-alcoholic steatohepatitis (NASH) for the liver specialist |
|
|
|
|
|
| |
 |
| Educational Webinar |
Presented by:
Doug Dieterich, MD |
|
|
| |
|
| Building a Multi-Departmental Fatty Liver Management Program |
|
|
|
|
| |
 |
| Educational Webinar |
Presented by:
Stephen Harrison, MD |
|
|
| |
|
| NAFLD - NASH Treatment Outlook |
|
|
|
|
| |
 |
| Educational Webinar |
Presented by:
Zobair M Younossi, MD, MPH, FACG, AGAF, FAASLD |
|
|
| |
|
| Epidemiology and Pathophysiology of NAFLD - NASH |
|
|
|
|
| |
 |
| Educational Webinar |
Presented by:
Mazen Noureddin, MD |
|
|
| |
|
| Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH |
|
|
|
|
| |
 |
| Educational Webinar |
Presented by:
Mark Sulkowski, MD |
|
|
| |
|
| Implications of NAFLD in People with HIV |
|
|
|
|
| |
 |
| Educational Webinar |
Presented by:
Michael Charlton, MD |
|
|
| |
|
| Implications of the NAFLD Epidemic on the Future of Liver Transplantation |
|
|
|
|
| |
 |
| |
| CME Audiocast |
Presented by:
Zobair Younossi, MD
|
|
| |
|
|
| Release date: |
| Apr 30, 2019 |
| |
| Expiration date: |
| Apr 30, 2020 |
|
|
| Updates in the Management of NASH |
|
|
|
|
|
|
|
| |
| 2018 |
| |
 |
| Educational Webinar |
Presented by:
Kenneth Cusi, MD |
|
|
| |
|
| Clinical Updates in the Management of Fatty Liver Disease in Patients with Type 2 Diabetes |
|
|
|
|
| |
 |
| Educational Webinar |
Presented by:
Miriam Vos, MD |
|
|
| |
|
| Fatty Liver Disease in Adolescent and Pediatric Patients |
|
|
|
|
| |
|
| |
|
| |
 |
|
|
| |
|
| AASLD 2018 Practice Guidance for Diagnosis and Management of NAFLD |
|
|
|
|
| |
| 2017 |
| |
 |
| |
| CME Webcast |
Presented by:
Christina Hanson, FNP-C |
|
| |
|
|
| Release date: |
| Dec 01, 2017 |
| |
| Expiration date: |
| Dec 01, 2018 |
|
|
| Current Approaches to Identifying and Managing Patients with NASH and What to Expect in the Future |
|
|
|
|
|
| |
 |
| |
| Educational Webinar |
Presented by:
Elliot B. Tapper, MD |
|
| |
|
|
| |
|
| The Evolving Role of Invasive and Non-Invasive Assessment Tools in Liver Disease |
|
|
|
|
| |
|
 |
| |
| Educational Webcast |
Presented by:
Stephen A. Harrison, MD, FACP, FAASLD |
|
| |
|
|
| |
|
| Utility of VCTE (Fibroscan®) as A Prescreen Tool for NAFLD Clinical Trials |
|
|
|
|
| |
|
| |
| 2016 |
 |
| |
| Educational Webcast |
Presented by:
Stephen A. Harrison, MD, FACP, FAASLD |
|
| |
|
|
| |
|
| Utility of VCTE (Fibroscan®) in the diagnosis of NAFLD/NASH |
|
|
|
|
| |
|
| |
 |
| |
| Educational Webcast |
Presented by:
Stephen Harrison, MD |
|
| |
|
|
| |
|
| NASH: Disease state and diagnosis |
|
|
|
|
| |
|
| |
 |
| |
| Educational Webcast |
Presented by:
Rohit Loomba, MD |
|
| |
|
|
| |
|
| NASH: Diagnostic tools: biomarkers and imaging |
|
|
|
|
| |
|
| |
 |
| |
| Educational Webcast |
Presented by:
Mary Rinella, MD |
|
| |
|
|
| |
|
| NASH: Treatment update and the multidisciplinary approach from the hepatologist's perspective |
|
|
|
|
| |
|
| |
 |
| |
| Educational Webcast |
Presented by:
Kenneth Cusi, MD |
|
| |
|
|
| |
|
| NASH: Treatment update and the multidisciplinary approach from the endocrinologist's perspective |
|
|
|
|
| |
|
| |
|
| |
| Educational Webcast |
Presented by:
Stephen A. Harrison, MD, FACP, FAASLD |
|
| |
|
|
| |
|
| 2016 Expert Perspectives on NAFLD/NASH |
|
|
|
|
| |
|
|
